Andrea Baran
Overview
Explore the profile of Andrea Baran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhang H, Yu A, Baran A, Messing E
Radiat Oncol J
. 2021 Oct;
39(2):91-98.
PMID: 34619825
Purpose: About 40% of men diagnosed with prostate cancer (Pca) are ≤65 years of age. This study evaluates the risk of second cancer among young Pca patients treated with surgery...
12.
Rodgers T, Williams A, Baran A, Reagan P, Casulo C, Zent C, et al.
Leuk Lymphoma
. 2020 Oct;
62(3):598-605.
PMID: 33100068
Phosphoinositide-3-kinase (PI3K) inhibitors have efficacy in lymphoid malignancies; however, inflammatory and infectious toxicities can compromise the treatment course. An improved understanding of these toxicities will guide clinical use and further...
13.
Wallace D, Cochran D, Duff J, Close J, Murphy M, Baran A, et al.
J Cancer Educ
. 2020 Oct;
37(4):911-914.
PMID: 33057958
Quality improvement and patient safety education is an Accreditation Council for Graduate Medical Education (ACGME) common program requirement for hematology/oncology fellowships. Interprofessional clinical patient safety activities, such as root cause...
14.
Zhang H, Kang S, Ali N, Baran A, Bylund K, Gentile D, et al.
Adv Radiat Oncol
. 2020 Jun;
5(3):388-395.
PMID: 32529132
Purpose: Growing evidence supports the efficacy and safety of high-dose-rate (HDR) brachytherapy as a boost or monotherapy in prostate cancer treatment. We initiated a new HDR prostate brachytherapy practice in...
15.
Li F, Nielsen G, Baran A, Hu J, Wallace D, Preslar M, et al.
Clin Colorectal Cancer
. 2020 May;
19(3):e124-e128.
PMID: 32409226
Background: National Comprehensive Cancer Network guidelines for the treatment of locally advanced rectal cancer advocate neoadjuvant chemoradiotherapy followed by total mesorectal excision and adjuvant chemotherapy (AC). The aim of this...
16.
Rodgers T, Baran A, Reagan P, Casulo C, Zent C, Evans A, et al.
Br J Haematol
. 2019 Dec;
188(4):e33-e36.
PMID: 31845324
No abstract available.
17.
Loh K, Baran A, Lee C, Alshaibani A, Rutherford S, Hu J, et al.
Leuk Lymphoma
. 2019 Jul;
60(14):3569-3572.
PMID: 31282781
No abstract available.
18.
Abdelhakim H, Shune L, Bhatti S, Cantilena A, Baran A, Lin T, et al.
Biol Blood Marrow Transplant
. 2019 Jun;
25(9):1713-1719.
PMID: 31170519
Patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation (auto-HCT) are at risk for multiple morbidities, including mucosal inflammation and neutropenic fever, both related to neutropenia. Evidence from our preclinical...
19.
Kerns S, Fachal L, Dorling L, Barnett G, Baran A, Peterson D, et al.
J Natl Cancer Inst
. 2019 May;
112(2):179-190.
PMID: 31095341
Background: A total of 10%-20% of patients develop long-term toxicity following radiotherapy for prostate cancer. Identification of common genetic variants associated with susceptibility to radiotoxicity might improve risk prediction and...
20.
Schaffer K, Panneerselvam N, Loh K, Herrmann R, Kleckner I, Dunne R, et al.
J Natl Compr Canc Netw
. 2019 Jan;
17(1):57-63.
PMID: 30659130
Exercise can ameliorate cancer- and treatment-related toxicities, but poor adherence to exercise regimens is a barrier. Exercise interventions using digital activity trackers (E-DATs) may improve exercise adherence, but data are...